Skip to main content
. 2017 Dec 27;596(23):5925–5945. doi: 10.1113/JP274999

Table 7.

Plasma corticosteroids and thyroid hormones in the first week after birth

Female Male P values for treatment effect
CON FGRS FGRI CON FGRS FGRI
n = 11–15 n = 10–13 n = 10–12 n = 12—16 n = 10‐11 n = 9–10 Female Male
Day 1
Cortisol (ng mL−1) 70.1 ± 9.9 59.5 ± 9.5 52.5 ± 9.5 72.0 ± 25.8 64.3 ± 22.8 80.5 ± 24.2 ns ns
Cortisone (ng mL−1) 20.0 ± 5.6 22.2 ± 5.8 15.8 ± 5.8 20.1 ± 7.0 16.8 ± 6.8 21.7 ± 7.0 ns ns
ln 11‐deoxycortisol −0.8 ± 0.2 −1.2 ± 0.2 −1.1 ± 0.2 −0.8 ± 0.6 −1.0 ± 0.3 −0.6 ± 0.4 ns ns
ln cortisol:cortisone ratio 1.4 ± 0.2 1.5 ± 0.2 1.4 ± 0.2 1.4 ± 0.1 1.5 ± 0.1 1.5 ± 0.1 ns ns
Cortisol:11‐deoxycortisol ratio 155 ± 42 183 ± 45 123 ± 45 187 ± 16 144 ± 29 170 ± 33 ns ns
T3 (pg mL−1) 17.5 ± 1.7 14.0 ± 1.9 14.7 ± 2.2 18.0 ± 2.9 13.3 ± 2.9 11.9 ± 3.0 ns 0.04
T4 (pmol mL−1) 73.0 ± 4.5 49.7 ± 5.8 44.4 ± 7.5 59.3 ± 1.06 56.1 ± 10.4 49.8 ± 10.6 <0.01*† ns
ln T3:T4 tatio −1.4 ± 0.1 −1.3 ± 0.1 −1.2 ± 0.1 −1.2 ± 0.1 −1.4 ± 0.1 −1.5 ± 0.1 ns ns
Day 7
Cortisol (ng mL−1) 31.2 ± 8.8 39.2 ± 9.9 22.4 ± 9.8 25.5 ± 4.6 48.4 ± 8.3 31.7 ± 9.4 ns ns
Cortisone (ng mL−1) 8.3 ± 1.3 8.1 ± 1.5 5.5 ± 1.5 8.2 ± 0.7 10.8 ± 1.3 7.4 ± 1.5 ns ns
ln 11‐deoxycortisol −1.3 ± 0.5 −0.9 ± 1.2 −1.6 ± 1.3 −1.3 ± 0.4 −0.7 ± 0.4 −0.8 ± 0.5 ns ns
ln cortisol:cortisone ratio 1.6 ± 0.2 1.8 ± 0.2 1.9 ± 0.1 1.5 ± 0.1 1.5 ± 0.1 1.9 ± 0.1 ns ns
Cortisol:11‐deoxycortisol ratio 98.5 ± 16.9 76.0 ± 19.4 80.6 ± 19.2 73.4 ± 15.7 76.7 ± 14.0 65.1 ± 15.4 ns ns
T3 (pg mL−1) 16.0 ± 0.6 16.7 ± 0.7 16.1 ± 0.7 15.7 ± 1.3 15.6 ± 1.2 14.5 ± 1.3 ns ns
T4 (pmol mL−1) 45.2 ± 1.1 44.0 ± 1.3 36.8 ± 1.2 41.2 ± 2.6 39.5 ± 2.4 36.3 ± 2.6 <0.0001*‡ ns
ln T3:T4 ratio −1.5 ± 0.1 −1.1 ± 0.1 −1.1 ± 0.1 −1.2 ± 0.1 −1.2 ± 0.1 −1.2 ± 0.1 ns ns

Absolute plasma corticosteroids and thyroid hormones, natural log transformation (ln) of plasma corticosteroids and thyroid hormones and ratios at birth (Day 1) and 7 days after birth. l‐3,3′,5‐triiodothyronine (T3), thyroxine (T4). Data are means ± SEM. Symbols denote significant differences amongst experimental groups upon post hoc testing: *CON vs. FGRS; CON vs. FGRI; FGRS vs. FGRI; ns, not significant.